2Yund EE, Hill JA,Keller RS. Hic-5 is required for fetal gene ex-pression and cytoskeletal organization of neonatal cardiac myo-cytes[J]. J Mol Cell Cardiol,2009,47(4) :520-527.
3Thomas SM,Hagel M,Turner CE. Characterization of a focal ad-hesion protein, Hic-5, that shares extensive homology with paxil-lin[J]. J Cell* Sci,1999,112(Pt 2):181-190.
4Deakin NO, Turner CE. Distinct roles for paxillin and Hic-5 inregulating breast cancer cell morphology, invasion, and metastasis[J]. Mol Biol Cell,2011,22(3) :327-341.
5Shola DT, Wang H, Wahdan-Alaswad R, et al. Hic-5 controlsBMP4 responses in prostate cancer cells through interacting withSmads 1,5 and 8[J]. Oncogene,2012,31 (19) :2480-2490.
6Matsuura S,Kondo S,Suga K, et al. Expression of focal adhesionproteins in the developing rat kidney[J]. J Histochem Cytochem,2011,59(9):864-874.
7Kim-Kaneyama JR, Wachi N,Sata M,et al. Hic-5 . an adaptor pro-tein expressed in vascular smooth muscle cells,modulates the ar-terial response to injury in vivo[J], Biochem Biophys Res Com-mun,2008,376(4):682-687.
8Wang H,Song K,Krebs TL,et al. Smad7 is inactivated through adirect physical interaction with the LIM protein Hic-5/ARA55[J]. Oncogene,2008,27(54):6791-805.
9Aghajanova L, Velarde MC,Giudice LC. The progesterone recep-tor coactivator Hic-5 is involved in the pathophysiology of endo-metriosis[J]. Endocrinology ,2009,150(8) : 3863-3870.
10Heitzer MD, DeFranco DB. Mechanism of action of Hic-5/andro-gen receptor activator 55,a LIM domain-containing nuclear recep-tor coactivator[J]. Mol Endocrinol.2006,20(1) :56-64.
